{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/palliative-care-malignant-skin-ulcer/","result":{"data":{"firstChapter":{"id":"8aae23f3-652c-5220-96a9-570f5c6a4197","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field c3a553b2-3597-40f4-9189-c6e6b867975c --><h1>Palliative care - malignant skin ulcer: Summary</h1><!-- end field c3a553b2-3597-40f4-9189-c6e6b867975c -->","htmlStringContent":"<!-- begin item 622bc110-ebcb-43c8-a5aa-1cd3eb8b2d43 --><!-- begin field 7bc79d68-6dd6-4bb3-9598-f25d525ac209 --><ul><li>A malignant ulcer is a proliferative or cavitating primary or secondary cancer in the skin.<ul><li>It may appear as a crater-like wound, a nodular 'fungus', or a 'cauliflower' lesion.</li></ul></li><li>Most malignant ulcers develop from a breast, head and neck, or skin cancer.</li><li>Malignant ulcers are most likely to develop in people older than 70 years of age with metastatic cancer and a life expectancy of 6 months or less.</li><li>Primary care management of a malignant skin ulcer includes:<ul><li>Assessment of the malignant skin ulcer including the type, site and size of the ulcer, the presence of necrotic tissue, condition of the surrounding skin, and the presence of complications.</li><li>Discussing with the person their concerns, treatment priorities, and advising that healing is unlikely to be a realistic goal, but that the aim is to maintain the person’s quality of life as much as possible.</li><li>Ensuring a professional with expertise in wound management is involved in the person's care (such as a district nurse, palliative care or tissue viability nurse). This professional can advise on the need for cleansing, debridement, and the correct selection and use of dressings.</li><li>Referral where appropriate to an oncologist or palliative care specialist for advice if further cancer treatment is possible (such as radiotherapy, chemotherapy, hormone therapy, or surgical intervention).</li></ul></li><li>Principles of management of common complications in primary care include:<ul><li>Pain — identifying and treating the cause where possible, using appropriate analgesia, and ensuring the use of breakthrough analgesia before dressing changes if required.</li><li>Infection — taking a swab and using an appropriate antibiotic if indicated.</li><li>Bleeding — using gentle pressure for mild bleeding or seeking specialist advice for heavier bleeding as appropriate.</li><li>Exudate — protecting the surrounding skin and seeking specialist advice for the management of copious exudate.</li><li>Odour — prescribing topical or oral metronidazole where indicated and considering non-pharmacological measures.</li><li>Itch — considering the use of a mild topical corticosteroid.</li><li>Psychosocial issues — managing all symptoms appropriately and giving consideration to the cosmetic effect of dressings.</li></ul></li><li>Referral for specialist advice should be considered if symptoms are not controlled by primary care management.</li></ul><!-- end field 7bc79d68-6dd6-4bb3-9598-f25d525ac209 --><!-- end item 622bc110-ebcb-43c8-a5aa-1cd3eb8b2d43 -->","topic":{"id":"a66236f8-759a-578d-b8e0-d9b9f4d4b17b","topicId":"594ae15d-e8a6-49e1-9bc4-b8235684b211","topicName":"Palliative care - malignant skin ulcer","slug":"palliative-care-malignant-skin-ulcer","aliases":[],"chapters":[{"id":"8aae23f3-652c-5220-96a9-570f5c6a4197","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"3fae4ef2-1de8-537a-8d87-bb0f0e925ca2","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"7cd1b72b-f0ca-5fa9-a739-760c7315a4c6","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"28f3598f-1a0b-5fa6-885c-7908290eef3d","slug":"changes","fullItemName":"Changes"},{"id":"ee67bddb-c899-5cdf-8bd4-b6ce53a64863","slug":"update","fullItemName":"Update"}]},{"id":"7209a66f-e985-5a26-b178-2d841634478d","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"a512b109-ae33-58f1-9b3e-1bb25ba17ed1","slug":"goals","fullItemName":"Goals"},{"id":"d4f96da2-1dfd-5b18-aeec-d33fe0b56967","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"ec220b93-2051-5b93-ada7-66029759c688","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e8a03776-8e6f-57f0-9d78-72e639758d72","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a89f6107-4d65-56f2-a108-583acc3aa1dd","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"99d9f654-11a9-5749-882a-6bfac0a995ad","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ba712e36-e31f-53bb-9746-10f4bb36e7e9","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"8ae192ef-3ead-55f6-b5dc-e15c6fbe8e92","slug":"definition","fullItemName":"Definition"},{"id":"6045e3e4-960f-5f2a-949e-66eaa7d7fd27","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"fb13b65f-08f4-5ac4-b21a-bbba9bec2bce","slug":"complications","fullItemName":"Complications"}]},{"id":"5750038d-2dca-5b1b-9cef-5ec97727cd6c","slug":"management","fullItemName":"Management","subChapters":[{"id":"576c0eda-301a-5d5f-9d9f-34505854cac8","slug":"palliative-cancer-care-malignant-skin-ulcer","fullItemName":"Scenario: Palliative cancer care - malignant skin ulcer"},{"id":"4c917ea3-8a66-5e50-9cd2-a4494533a824","slug":"end-of-life-care","fullItemName":"Scenario: End of life care"}]},{"id":"c6fd3a21-3f33-5f10-9f9b-22da77001d52","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"cce56ef7-baec-5a1f-9927-a88b697e0b79","slug":"metronidazole","fullItemName":"Metronidazole"}]},{"id":"6fb5a8ca-5e8b-5cea-9647-c8d15aa9fd31","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"c16178c4-497b-57f0-8903-94f79dc3e888","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"0676abc6-76ab-5fcf-816a-0f0fd3c08737","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7c58ec18-ffff-5082-9660-ff776be47414","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"ec9b77b3-9f46-5d3d-89fe-1d2ba54e8e03","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2b921fab-b857-5da1-90cd-616aa087e15a","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f5f487fa-4ace-58e9-aefa-a01924f86557","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"0a5cfba7-db2d-58b1-b705-aef0029b384e","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"a66236f8-759a-578d-b8e0-d9b9f4d4b17b","topicId":"594ae15d-e8a6-49e1-9bc4-b8235684b211","topicName":"Palliative care - malignant skin ulcer","slug":"palliative-care-malignant-skin-ulcer","aliases":[],"topicSummary":"A malignant ulcer is a proliferative or cavitating primary or secondary cancer in the skin.It may appear as a crater-like wound, a nodular 'fungus'","lastRevised":"Last revised in October 2018","nextPlannedReviewBy":"2021-10-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2021-09","nextPlannedReviewByDisplay":"September 2021","specialities":[{"id":"50071c38-ab10-5ab8-ac70-6bd19a96c24e","name":"Skin and nail","slug":"skin-nail"},{"id":"ad789c56-a29e-5319-92cd-223890d75f09","name":"Palliative care","slug":"palliative-care"}],"chapters":[{"id":"8aae23f3-652c-5220-96a9-570f5c6a4197","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"3fae4ef2-1de8-537a-8d87-bb0f0e925ca2","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"7cd1b72b-f0ca-5fa9-a739-760c7315a4c6","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"28f3598f-1a0b-5fa6-885c-7908290eef3d","slug":"changes","fullItemName":"Changes"},{"id":"ee67bddb-c899-5cdf-8bd4-b6ce53a64863","slug":"update","fullItemName":"Update"}]},{"id":"7209a66f-e985-5a26-b178-2d841634478d","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"a512b109-ae33-58f1-9b3e-1bb25ba17ed1","slug":"goals","fullItemName":"Goals"},{"id":"d4f96da2-1dfd-5b18-aeec-d33fe0b56967","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"ec220b93-2051-5b93-ada7-66029759c688","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e8a03776-8e6f-57f0-9d78-72e639758d72","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a89f6107-4d65-56f2-a108-583acc3aa1dd","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"99d9f654-11a9-5749-882a-6bfac0a995ad","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ba712e36-e31f-53bb-9746-10f4bb36e7e9","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"8ae192ef-3ead-55f6-b5dc-e15c6fbe8e92","slug":"definition","fullItemName":"Definition"},{"id":"6045e3e4-960f-5f2a-949e-66eaa7d7fd27","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"fb13b65f-08f4-5ac4-b21a-bbba9bec2bce","slug":"complications","fullItemName":"Complications"}]},{"id":"5750038d-2dca-5b1b-9cef-5ec97727cd6c","slug":"management","fullItemName":"Management","subChapters":[{"id":"576c0eda-301a-5d5f-9d9f-34505854cac8","slug":"palliative-cancer-care-malignant-skin-ulcer","fullItemName":"Scenario: Palliative cancer care - malignant skin ulcer"},{"id":"4c917ea3-8a66-5e50-9cd2-a4494533a824","slug":"end-of-life-care","fullItemName":"Scenario: End of life care"}]},{"id":"c6fd3a21-3f33-5f10-9f9b-22da77001d52","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"cce56ef7-baec-5a1f-9927-a88b697e0b79","slug":"metronidazole","fullItemName":"Metronidazole"}]},{"id":"6fb5a8ca-5e8b-5cea-9647-c8d15aa9fd31","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"c16178c4-497b-57f0-8903-94f79dc3e888","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"0676abc6-76ab-5fcf-816a-0f0fd3c08737","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7c58ec18-ffff-5082-9660-ff776be47414","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"ec9b77b3-9f46-5d3d-89fe-1d2ba54e8e03","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2b921fab-b857-5da1-90cd-616aa087e15a","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f5f487fa-4ace-58e9-aefa-a01924f86557","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"0a5cfba7-db2d-58b1-b705-aef0029b384e","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"a66236f8-759a-578d-b8e0-d9b9f4d4b17b"}},"staticQueryHashes":["3666801979"]}